Niacinamide: What the Evidence Actually Says About This Skin-Protecting Form of Vitamin B3
Niacinamide: What the Evidence Actually Says About This Skin-Protecting Form of Vitamin B3
📋 Simple Summary
Niacinamide — also called nicotinamide — is a form of vitamin B3. It's in the same vitamin family as niacin (the cholesterol one), but without the uncomfortable skin flush. Your body turns niacinamide into a molecule called NAD+, which every cell needs to make energy and repair damaged DNA, and which steadily drops as you get older. The strongest human evidence for niacinamide isn't about lifespan — it's about skin. A landmark 2015 trial of 386 high-risk adults found that 500 mg taken twice a day cut new skin cancers by 23% over a year. It also supports DNA repair, softens the wrinkles and brown spots of sun damage, and costs only pennies a day. For most people over 40 — especially anyone with a history of sun exposure or skin cancer — niacinamide is one of the best-evidence, lowest-risk supplements you can take.
The detailed breakdown continues below for those who want the full science.
Published: August 14, 2026
Evidence Tier: 🥈 Silver — One Gold-tier randomized trial for skin cancer prevention, a strong mechanistic basis for NAD+ support, but no direct human lifespan data.
Category: 💊 Supplements & Compounds
⚖️ At a Glance: Pros & Cons
⚠️ We are researchers, not doctors. Nothing on this page is medical advice. Niacinamide is generally very safe at the doses studied, but high doses can harm the liver. Talk to your doctor before starting any supplement — especially if you have liver disease, are pregnant, or take prescription medications.
✅ Pros
- Strongest benefit — skin cancer prevention: A Phase 3 trial of 386 high-risk adults found 500 mg twice daily reduced new non-melanoma skin cancers by 23% over 12 months.
- DNA repair support: Niacinamide helps cells repair UV-induced DNA damage and stops ultraviolet light from suppressing the skin's immune defenses.
- Visible skin-aging benefits: Reduces wrinkles, hyperpigmentation, and dullness — topical niacinamide is among the best-studied cosmetic actives there is.
- Safe, cheap, no flush: Unlike niacin, it causes no skin flushing, is well-tolerated at studied doses, and costs only pennies per day.
❌ Cons
- No human lifespan data: The longevity case rests on NAD+ biology and animal studies, not on any trial showing people live longer.
- Prevention, not reversal: Unlike rapamycin or senolytics, niacinamide mostly stops damage before it happens rather than reversing aging that's already occurred.
- High doses can harm the liver: Above roughly 3 grams per day, niacinamide can cause liver toxicity — stay well below this.
- Who should avoid: People with severe liver disease, and anyone pregnant should skip high-dose supplementation.
What Is Niacinamide?
Niacinamide is the amide form of vitamin B3. To understand where it fits, it helps to know that "vitamin B3" actually describes a small family of related molecules that do different things in the body:
- Niacin (nicotinic acid): The form used to manage cholesterol. It triggers a well-known skin "flush" (warmth, redness, itching) and is linked to liver stress at high doses.
- Niacinamide (nicotinamide): The subject of this article. No flush, no cholesterol effect — instead it feeds into NAD+ production and DNA repair. This is the form used in skin-cancer prevention trials.
- Nicotinamide riboside (NR) and NMN: Newer, more expensive NAD+ boosters with their own (weaker) human evidence base.
Niacinamide is water-soluble and found naturally in meat, fish, milk, eggs, green vegetables, beans, cereal grains, and yeast. Your body also makes some of it from the amino acid tryptophan. Because it isn't stored in large amounts, you need a steady supply from diet or supplements — and as we'll see, aging tends to drain the very pathway it feeds.
How It Works
1. It Feeds the NAD+ Pool
Inside your cells, niacinamide is recycled into nicotinamide adenine dinucleotide (NAD+), a coenzyme that hundreds of enzymes need to do their jobs — producing energy, repairing DNA, and switching genes on and off. This recycling route is called the salvage pathway: niacinamide → NMN → NAD+, driven by enzymes named NAMPT and NMNAT. NAD+ levels fall by roughly half between young adulthood and old age, and that decline is now considered one of the core features of biological aging.
2. It's a Mild PARP Inhibitor (This Is the Skin-Cancer Key)
When DNA gets damaged — say, by ultraviolet light — an enzyme called PARP jumps in to start repairs. The catch: PARP consumes NAD+ to do its job, and under heavy UV assault it can burn through so much NAD+ that the cell runs out of energy and its repair machinery stalls. Niacinamide gently reins in PARP, preserving the cell's NAD+ and ATP so repair can actually finish. This is the mechanism researchers credit for its skin-cancer-protective effect.
3. It Prevents UV From Suppressing Skin Immunity
Ultraviolet radiation doesn't just damage DNA directly — it also dials down the skin's immune surveillance, which is why sun-damaged skin is more likely to let a cancerous cell slip through. Niacinamide blocks this immunosuppression, keeping the immune system alert to abnormal cells.
4. It May Dial Back Cellular Senescence
Senescent cells are "zombie" cells that have stopped dividing but keep leaking inflammatory signals — a key driver of aging. A 2026 mouse study found that niacinamide delayed cellular senescence and suppressed the senescence-associated secretory phenotype (SASP) in UV-aged skin, an early hint that its anti-aging effect goes beyond surface-level cosmetics.
The Longevity Connection
🩺 Skin Cancer Prevention (Strongest Evidence)
The headline study is ONTRAC, a Phase 3 randomized controlled trial published in the New England Journal of Medicine in 2015. Researchers gave 386 adults (median age 66) who had already had at least two skin cancers either 500 mg of niacinamide twice a day or a placebo for 12 months. The niacinamide group developed 23% fewer new non-melanoma skin cancers, including 20% fewer basal cell carcinomas and 30% fewer squamous cell carcinomas, plus 13% fewer pre-cancerous spots (actinic keratoses). Side effects were no different from placebo. This is the kind of clean, reproducible, human result that most supplements never achieve.
🧴 Skin Appearance and Photoaging
Beyond cancer, niacinamide is one of the best-evidenced ingredients in skincare. Topical niacinamide (usually 2–5%) reduces fine lines, blotchiness, hyperpigmentation, and the yellowing that comes with sun damage, and improves elasticity and barrier function. Oral niacinamide appears to support the same biology from the inside, and a 2026 review in the International Journal of Molecular Sciences tied both effects to the same NAD+-repair pathway.
⚡ NAD+ and Metabolic Aging (Mechanistic)
Because niacinamide feeds NAD+ synthesis, it sits at the center of the current longevity conversation about NAD+ decline and the sirtuins — a family of enzymes that depend on NAD+ and are linked to lifespan regulation in animals. The honest caveat: boosting NAD+ has clearly extended lifespan in worms and mice in some studies, but whether any NAD+ precursor meaningfully slows human aging remains unproven. Niacinamide's human track record is strongest for skin outcomes, not lifespan.
🛡️ Immune Function
By preventing UV-induced immunosuppression, niacinamide keeps the skin's immune defenses intact — directly relevant to the higher skin-cancer rates seen in organ-transplant recipients and others on immune-suppressing drugs, a group where oral niacinamide is increasingly used off-label.
🧠 Brain (Emerging, Weaker)
Niacinamide appears in some neuroprotective formulations (for example, the stroke drug Cytoflavin, which combines it with inosine and riboflavin). The evidence for a standalone cognitive benefit is thin, and the 2026 trials testing NAD+ precursors for neurological conditions have used NR, not plain niacinamide.
Key Studies
| Study | Design | Key Finding |
|---|---|---|
| Chen et al. (2015) — ONTRAC N Engl J Med |
Phase 3 double-blind RCT (n=386 high-risk adults, 12 months) | 500 mg twice daily reduced new non-melanoma skin cancers by 23%, basal cell carcinomas by 20%, squamous cell carcinomas by 30%, and actinic keratoses by 13%. No increase in adverse events. |
| Bishnoi et al. (2026) Int J Mol Sci |
Review of clinical and mechanistic evidence | Summarizes the biological rationale linking niacinamide's NAD+ salvage, DNA-repair, and immune effects to both skin-cancer prevention and anti-aging. |
| (2026) JAMA Dermatology |
Cost-effectiveness analysis (VHA data) | Oral nicotinamide is cost-saving for preventing keratinocyte (skin) cancers in high-risk patients. |
| (2026) J Am Acad Dermatol |
Real-world propensity-matched analysis (TriNetX database) | Niacinamide supplementation associated with reduced melanoma and non-melanoma skin cancers outside a trial setting. |
| (2026) Curr Issues Mol Biol |
Mouse model of UV-induced skin photoaging | Nicotinamide delayed cellular senescence and suppressed the senescence-associated secretory phenotype (SASP) in photoaged skin. |
| (2026) Ital J Dermatol Venereol |
9-month follow-up controlled study | A nicotinamide-containing sunscreen helped prevent recurrence of actinic keratoses after treatment. |
| (2026) Lancet Neurology |
Phase 2 RCT of exercise + NAD+ precursor (NR) in Friedreich's ataxia | Context for the NAD+-precursor field — note this trial used nicotinamide riboside (NR), not plain niacinamide. |
Dosing and Safety
Recommended Forms
| Form | Notes | Best For |
|---|---|---|
| Niacinamide / nicotinamide (oral) | The form used in the ONTRAC trial; no flush; inexpensive | Skin-cancer prevention, NAD+ support |
| Niacinamide (topical, 2–5%) | Creams and serums; best-studied cosmetic active | Wrinkles, hyperpigmentation, redness |
| Nicotinic acid (niacin) | Different form — causes flushing; used for cholesterol | Not interchangeable with niacinamide for skin |
| Nicotinamide riboside (NR) / NMN | Pricier NAD+ boosters; separate evidence base | Alternatives if seeking a dedicated NAD+ supplement |
Dosing Protocol
| Goal | Daily Dose | Notes |
|---|---|---|
| Skin-cancer prevention (evidence-based) | 500 mg twice daily (1,000 mg total) | The exact ONTRAC trial dose. Best for people with a history of skin cancer or heavy sun exposure. |
| General skin / anti-aging | 250–500 mg once daily | A lower-cost maintenance dose. Can pair with a topical 2–5% niacinamide. |
| Topical (skin appearance) | 2–5% cream/serum, once or twice daily | Apply to face; well-tolerated by most skin types. |
| Do not exceed: | Stay well under ~3 g/day | Liver toxicity has been reported at very high doses (above ~3 g/day). There is no reason to go near this. |
Safety and Side Effects
| Concern | Details |
|---|---|
| Upper limit | No established upper limit for the niacinamide form (the 35 mg/day limit applies to nicotinic acid, which causes flushing). Still, keep well below ~3 g/day. |
| Common side effects | Rare at 500–1,000 mg/day. Occasional mild nausea or stomach upset at higher doses. No flushing (unlike niacin). |
| Most serious risk | Liver toxicity at very high doses (above ~3 g/day). This is dose-dependent and reversible when the supplement is stopped. |
| Drug interactions | Minimal and uncommon. As always, review with your doctor if you take prescription medications or have liver disease. |
| Who benefits most | Fair-skinned adults, anyone with a history of sun exposure or actinic keratoses, people who've had skin cancer, and organ-transplant recipients (who are at very high skin-cancer risk). |
❓ Common Questions About Niacinamide
What is niacinamide and how does it work?
Niacinamide (nicotinamide) is a form of vitamin B3 that doesn't cause the skin flush associated with niacin. Your body converts it into NAD+, a molecule every cell needs to make energy and repair damaged DNA. It also helps skin cells fix the DNA damage caused by ultraviolet light and stops sunlight from weakening the skin's immune defenses.
What does the evidence actually show?
The strongest evidence (Gold-tier) is for skin-cancer prevention: a Phase 3 trial of 386 high-risk adults found 500 mg twice daily cut new skin cancers by 23% over a year. There is also good (Silver-tier) evidence that it improves wrinkles, blotchiness, and sun damage. The idea that it extends lifespan is still unproven — it rests on NAD+ biology and animal studies, not human lifespan data.
What's the right dose?
For skin-cancer prevention, the evidence-based dose is 500 mg twice a day (1,000 mg total) — the exact dose used in the landmark trial. For general skin and anti-aging support, 250–500 mg once a day is reasonable. Topical products use 2–5% niacinamide applied to the skin.
What are the risks and side effects?
Niacinamide is very well tolerated at the studied doses — the landmark trial found side effects no different from a placebo, and it causes none of the flushing that niacin does. Mild nausea can occur at higher doses. The one serious risk is liver damage, but that only appears at very high doses above roughly 3 grams per day.
Who should avoid it?
People with severe liver disease should avoid niacinamide, and anyone pregnant or nursing should skip high-dose supplementation. If you take prescription medications or have a medical condition, check with your doctor first. Everyone else should simply stay well below the very high doses linked to liver problems.
The Bottom Line
Evidence Hierarchy
The evidence for niacinamide is strongest where the human data is most direct: preventing non-melanoma skin cancer. That's backed by a clean Phase 3 randomized trial — a rarity in the supplement world. The evidence for visible skin-aging benefits is also solid, especially for topical use. The evidence for NAD+ replenishment and "anti-aging" in the broader longevity sense is mechanistically sound but not yet proven in human lifespan terms.
Our Verdict
For anyone with a history of sun exposure or skin cancer: niacinamide at 500 mg twice daily is one of the highest-value, lowest-risk interventions available. It's cheap, essentially side-effect-free at that dose, and directly lowers your risk of the most common cancer in the United States.
For the general longevity-curious: a lower dose of 250–500 mg a day is a reasonable, inexpensive way to support your NAD+ pathway — but be honest about what it is. Niacinamide is a prevention and DNA-repair tool, not a lifespan drug like rapamycin or a senolytic like fisetin. It won't make you younger, but it may help keep your skin — and the cells beneath it — in better repair as you age.
Who benefits most: fair-skinned and sun-exposed adults, people with actinic keratoses or a prior skin cancer, and transplant recipients (who face a dramatically elevated skin-cancer risk). If that's you, this is a supplement worth discussing with your dermatologist.
Medical Disclaimer: This page is for informational purposes only and does not constitute medical advice. Niacinamide is generally safe at the doses studied, but high doses can harm the liver and it may not be appropriate for everyone. Always consult your healthcare provider before starting any supplement, especially if you are pregnant, nursing, have liver disease, or take prescription medications. Skin cancer is serious — niacinamide is not a substitute for sun protection or regular skin checks.
Sources
- Chen AC, Martin AJ, Choy B, et al. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention. N Engl J Med. 2015;373(17):1618-26. PMID: 26488693
- Skin Cancer Prevention and Antiaging: Role of Nicotinamide. Int J Mol Sci. 2026. PMID: 42278444
- Cost-Effectiveness of Oral Nicotinamide for Keratinocyte Carcinoma Prevention. JAMA Dermatol. 2026. PMID: 42268603
- Niacinamide supplementation for chemoprophylaxis of melanoma and nonmelanoma skin cancer: a real-world propensity-matched analysis of the TriNetX database. J Am Acad Dermatol. 2026. PMID: 42002078
- Considering Body Mass Index for Skin Cancer Prevention Using Oral Nicotinamide. Nutr Cancer. 2026. PMID: 42066006
- Nicotinamide Improves Skin Photoaging in Mice by Delaying Cellular Senescence and Suppressing the Senescence-Associated Secretory Phenotype. Curr Issues Mol Biol. 2026. PMID: 42510902
- Advanced nicotinamide-containing broad-spectrum sunscreen could prevent actinic keratosis relapse after lesion-directed or field-directed treatment. Ital J Dermatol Venereol. 2026. PMID: 41950053
- Safety and efficacy of individualised exercise and NAD+ precursor supplementation in Friedreich's ataxia. Lancet Neurol. 2026. PMID: 42009009
- Intravenous longevity therapy: a critical review of evidence, mechanisms, and clinical utility. Acta Dermatovenerol Alp Pannonica Adriat. 2026. PMID: 41915584